Your session is about to expire
← Back to Search
Supportive care (group therapy sessions) for Blood Cancers
Study Summary
"This trial is testing if acceptance and commitment therapy and compassion-based virtual group therapy can help improve the mental well-being of cancer patients. Cancer diagnosis and treatment can lead to distress and decreased quality of life,
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the enrollment for this medical study currently accepting new participants?
"According to clinicaltrials.gov, this investigation is currently seeking potential participants. The initial posting date of the trial was December 26th, 2023, with the latest update noted on January 30th, 2024."
What are the projected results that researchers hope to achieve with this investigation?
"The primary focus of this investigation is to gauge the perceived compassion and understanding from the group therapy provider as measured by SCQ, spanning from baseline to 1 month post session 6. Secondary objectives encompass examining Meaning and purpose utilizing a 5-item Presence of Meaning subscale derived from the MLQ, evaluating Self-compassion with a 12-item SCS-SF scale rating responses on a range from almost never (1) to almost always (5), and scrutinizing Posttraumatic growth through a 10-item PTGI-SF survey graded between 0 denoting no change following cancer diagnosis up to 5 depicting significant impact experienced"
What is the current number of participants involved in this research investigation?
"Affirmative. Records on clinicaltrials.gov display that this trial is currently open for enrollment. Initially shared on December 26, 2023, and last revised on January 30, 2024, the study aims to recruit a total of 200 participants from one designated site."
Share this study with friends
Copy Link
Messenger